Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- $174.9M
- Net margin
- —
Little or no net debt.
- Total debt
- $733K
- Cash
- $15.2M
- Net debt / EBITDA
- -0.10x
Comfortably covers what is due within a year.
- Current assets
- $53.4M
- Current liabilities
- $10.7M
- Current ratio
- 4.98
Consumes cash and must keep raising it.
- Operating cash flow
- -$5.6M
- Free cash flow
- -$5.4M
Not funding itself by issuing shares.
- Shares outstanding
- 41.0M
- Share growth (1y)
- -1.7%
- Cash runway
- 33 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
ORMP Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 M |
| Revenue Growth (YoY) | — | -100.00 % | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 30.00 K | 31.00 K | 0.00 | 1.99 M |
| Gross Profit | 0.00 | 0.00 | -30.00 K | -31.00 K | 0.00 | 13.00 K |
| SG&A Expense | 2.77 M | 2.06 M | 3.65 M | 1.27 M | 1.46 M | 2.31 M |
| R&D Expense | 0.00 | 1.59 M | 1.99 M | 1.15 M | 1.03 M | 2.21 M |
| Operating Expenses | 2.77 M | 3.66 M | 5.64 M | 2.40 M | 2.49 M | 4.51 M |
| Operating Income | -2.77 M | -3.66 M | -5.67 M | -2.43 M | -2.49 M | -4.50 M |
| Pretax Income | 101.59 M | 49.44 M | 9.80 M | 59.45 M | 13.13 M | -7.06 M |
| Tax Provision | 23.43 M | 11.13 M | -212.00 K | 11.06 M | -126.00 K | 584.00 K |
| Net Income | 78.16 M | 38.31 M | 10.01 M | 48.40 M | 13.29 M | -7.64 M |
| EPS (Basic) | 1.90 | 0.94 | 0.23 | 1.16 | 0.32 | -0.19 |
| EPS (Diluted) | 1.84 | 0.91 | 0.23 | 1.13 | 0.31 | -0.19 |
| Shares Outstanding | 41.04 M | 40.77 M | 40.45 M | 41.76 M | 41.74 M | 41.23 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.